On today's episode of PopHealth Week, our guest is Eddie Martucci, PhD, co-founder & CEO of Akili Interactive, a company getting to the root of cognitive impairment by creating personalized digital therapeutics engineered to directly improve cognitive impairments.
The impact of value assessment frameworks on formulary decision-making continues to create debate and influence manufacturers’ evidence-gathering strategies. Join our expert panel as they explore the evolving landscape of these frameworks, uncover payer perspectives, discuss questions and considerations regarding the real-world application, and forecast emerging trends that will shape value assessment in the future.
The impact of value assessment frameworks on formulary decision making continues to create debate and influence manufacturers’ evidence-gathering strategies. Join our expert panel as they explore the evolving landscape of these frameworks, uncover payer perspectives, discuss questions and considerations regarding the real-world application, and forecast emerging trends that will shape value assessment in the future.
Where We Stand: AMCP opposes statutory and regulatory proposals that unduly restrict the ability of pharmacists working within managed care organizations from utilizing tools and services that are essential for the management of a prescription drug benefitFind out about Regulation of the Prescription Drug Benefit.
Where We Stand: AMCP believes that a health care delivery system that is based upon a competitive marketplace will provide greater value to patients and payers than a system that is one‐size‐fits‐all that relies on centralized governmental controls and regulatory mandates.
Today, the Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announced that it has received a major grant from the Food & Drug Administration (FDA) in support of biosimilars research. The award provides $1.3 million over two years for a new BBCIC study focused on increasing the efficiency of biosimilar drug development and review.
On August 4, the Department of Health and Human Services released a Notice of Proposed Rulemaking on Nondiscrimination in Health Programs and Activities. In response, AMCP submitted comments on September 29 which applaud the Department's goal to reinstate regulatory protections from discrimination in covered health programs and activities.